Asymptomatic and mild primary hyperparathyroidism

被引:11
|
作者
Macfarlane, David P. [1 ,2 ]
Yu, Ning [3 ]
Leese, Graham P. [2 ]
机构
[1] Raigmore Hosp, Dept Med, Inverness IV2 3UJ, Scotland
[2] Univ Dundee, Ninewells Hosp & Med Sch, Div Cardiovasc & Diabet Med, Dundee DD1 9SY, Scotland
[3] Univ Dundee, Div Populat Hlth Sci, Dundee Epidenziol & Biostat Unit, Dundee, Scotland
关键词
Primary hyperparathyroidism; Mild and asymptomatic primary hyperparathyroidism; Hypercalcaemia; BONE-MINERAL DENSITY; UNTREATED PRIMARY HYPERPARATHYROIDISM; CARDIOVASCULAR RISK-FACTORS; 4TH INTERNATIONAL WORKSHOP; POSTMENOPAUSAL WOMEN; PARATHYROID SURGERY; SERUM-CALCIUM; AUDIT RESEARCH; FOLLOW-UP; ORAL ALENDRONATE;
D O I
10.1016/j.ando.2015.03.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary hyperparathyroidism is common, with epidemiological studies suggesting it may effect up to 1% of the population, and up to 3% of post-menopausal females. Many cases are diagnosed incidentally on routine blood sampling, with the majority of patients being seemingly asymptomatic at diagnosis, and often having mild hypercalcaemia of <2.85 mmol/L. Individuals with this so-called mild or asymptomatic primary hyperparathyroidism may however have undiagnosed complications, along with subtle neuropsychological symptoms, and possibly increased cardiovascular risk. Revised international guidelines suggest a more proactive approach to screening for vertebral fractures and renal stones, although the thresholds for recommending definitive surgical management with parathyroidectomy remain similar. The natural history of mild primary hyperparathyroidism will be reviewed, with particular reference to the Parathyroid Epidemiology and Audit Research Study (PEARS), which has used population level data from Tayside, Scotland (UK), along with recent data describing an association with cardiovascular disease. Results of intervention studies, including randomised controlled trials, will also be discussed. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:120 / 127
页数:8
相关论文
共 50 条
  • [41] Bone densitometry in asymptomatic primary hyperparathyroidism
    Miller, PD
    Bilezikian, JP
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : N98 - N102
  • [42] The diagnosis and management of asymptomatic primary hyperparathyroidism
    Silverberg, Shonni J.
    Bilezikian, John P.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2006, 2 (09): : 494 - 503
  • [43] Bone measurements in asymptomatic primary hyperparathyroidism
    Adami, S
    Braga, V
    Squaranti, R
    Rossini, M
    Gatti, D
    Zamberlan, N
    BONE, 1998, 22 (05) : 565 - 570
  • [44] ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM - TREATMENT OR OBSERVATION
    JOCKENHOVEL, F
    REINWEIN, D
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1994, 119 (27) : 967 - 973
  • [45] Asymptomatic primary hyperparathyroidism: a surgical perspective
    Mack, LA
    Pasieka, JL
    SURGICAL CLINICS OF NORTH AMERICA, 2004, 84 (03) : 803 - +
  • [46] MYOCARDIAL CALCIFICATIONS IN ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM
    ORTIZ, O
    SILVERBERG, SJ
    KATRANDJIAN, I
    SAVOIA, MT
    HOMMA, S
    BILEZIKIAN, JP
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S502 - S502
  • [47] An Uncommon Cause of Asymptomatic Primary Hyperparathyroidism
    Abate, Ejigayehu G.
    Bernet, Victor
    May, Gerald R.
    Smallridge, Robert C.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (12): : 4304 - 4305
  • [48] Asymptomatic primary hyperparathyroidism presenting with dementia
    Papageorgiou, S. G.
    Christou, Y.
    Kontaxis, T.
    Bonakis, A.
    Potagas, C.
    Anagnostouli, M.
    Kalfakis, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 186 - 186
  • [49] Asymptomatic primary hyperparathyroidism in women.
    Spivacow, Francisco R.
    Palumbo, Claudia
    MEDICINA-BUENOS AIRES, 2017, 77 (03) : 196 - 200
  • [50] Asymptomatic primary hyperparathyroidism - need to treat?
    Raue, F
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2000, 108 (04) : 247 - 248